chr2-58123198-T-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_006296.7(VRK2):c.641T>C(p.Ile214Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000123 in 1,589,668 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006296.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000664 AC: 101AN: 152122Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000128 AC: 29AN: 226060Hom.: 0 AF XY: 0.000106 AC XY: 13AN XY: 122578
GnomAD4 exome AF: 0.0000661 AC: 95AN: 1437546Hom.: 2 Cov.: 30 AF XY: 0.0000559 AC XY: 40AN XY: 714930
GnomAD4 genome AF: 0.000664 AC: 101AN: 152122Hom.: 0 Cov.: 32 AF XY: 0.000713 AC XY: 53AN XY: 74298
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.641T>C (p.I214T) alteration is located in exon 8 (coding exon 7) of the VRK2 gene. This alteration results from a T to C substitution at nucleotide position 641, causing the isoleucine (I) at amino acid position 214 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at